Compugen (Israel)
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Compugen (Israel), Israel, covering academic research published from 2000 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
163
Total Open
Publications
87
Total
Citations
13K
Open Access
Percentage
53%
Total
Publications
163
Total Open
Publications
87
Total
Citations
13K
Breakdown
Publisher Open
14%
Both
23%
Other Platform Open
16%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 30%
18
Hybrid 33%
20
No Guarantees 37%
22
Other Platform Open
Domain 66%
42
Preprint 19%
12
Public 17%
11
Other Internet 17%
11
Institution 13%
8
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 42 |
Europe PMC | Domain | 39 |
Figshare | Public | 12 |
DOI | Other Internet | 9 |
arXiv | Preprint | 7 |
Semantic Scholar | Public | 5 |
University of Bristol - Bristol Research | Institution | 4 |
University College London - UCL Discovery | Institution | 4 |
CiteSeer X | Other Internet | 4 |
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna | Institution | 4 |